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New Zealand Black (NZB) and NZB/NZW F1 hybrid mice are genetically predis- 
posed to an immunologic disorder characterized by autoantibody formation, hemolytic 
anemia, lymphoid infiltration of many organs, immune complex nephritis,  and lym- 
phoid malignancies (1-3). They have been studied as a laboratory model for systemic 
lupus erythematosus (4) and Sj6gren's syndrome (5).  Immunologi  c and viral factors 
have been implicated in their disease  (1, 2, 4). 
Certain immunologic abnormalities,  such as excessive  antibody responses to some 
antigens  (6,  7)  and  relative  resistance  to tolerance  induction  (7-9),  are present  in 
these animals before any signs of disease.  Other abnormalities,  such as impaired cell- 
mediated immunity (10-13), develop after autoimmunity is present. An antibody cy- 
totoxic for thymus-derived lymphocytes (T cells) is present early in life (14) and may 
contribute to a progressive loss of T cell effector functions and slight decrease in 0-posi- 
tive lymphocytes (15-18). Their general immune status can be summarized as an im- 
balance between excessive  antibody responses and diminished cellular immunity (4). 
New Zealand mice harbor a Gross-type leukemia virus (19, 20) and make antibodies 
to viral antigens (21). Whether this is the ubiquitous natural virus common to AKR 
and many other mouse strains or whether it is a unique agent is an important unre- 
solved question. Recent evidence suggests that the NZB virus does have some unusual 
properties (22, 23). 
Serum IgM concentrations are increased in New Zealand Black mice (24, 25).  East 
and her colleagues could observe no correlation between serum IgM concentration and 
sex,  clinical status,  thymic infiltration,  or kidney disease.  One NZB serum showed a 
"local increase" of IgM on immunoelectrophoresis suggestive of a paraprotein (25). A 
high IgM is not prevented by neonatal thymectomy or by maintenance in a germ-free 
environment (3). Another group found IgM cryoglobulins, some with immunoelectro- 
phoretic characteristics  suggestive of a  monoclonal disorder,  in about 22%  of NZB 
mice (26). 
The autoantibodies that can be detected on the erythrocyte surface in Coomb's posi- 
tive NZB mice are heterogeneous. Warner and Wistar found greater amounts of IgG 
than of IgM coating these erythrocytes (24). Likewise,  IgG is the major immunoglobu- 
lin  present  in  the  immune  complexes that  deposit  in  the  glomeruli  of NZB/NZW 
(B/W) F1 mice (27). 
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NZB mice over 1 yr of age have an increased incidence of lymphoid malignancy (3, 
28,  29).  Generalized reticulum  cell sarcoma,  thymoma,  and  lymphocytic lymphoma 
have been observed. Mellors described a "pleomorphic malignant lymphoma" that, in 
one mouse,  was  associated with a  peak  in the B-T-globulin region on paper  electro- 
phoresis  (29). A  narrow electrophoretic peak was also observed in serum of old NZB 
mice by Bhoopalam et al.  (30). 
Malignant lymphoma in NZB mice is potentiated by administration of the immuno- 
suppressive drug azathioprine  (31). High-dose cyclophosphamide given to B/W mice 
for 2 yr resulted in an increased incidence of lymphomas and  other neoplasms  (32). 
Two mice developed paraproteins. 
We now report the presence of electrophoretically restricted irnmunoglobulins 
in over 30%  of hybrid  B/W  mice greater  than  11 mo of age.  20 of these pro- 
teins  have  been  characterized  and  every  one  belongs  to  the  IgM  immuno- 
globulin class. Only a single light chain type was detected in 10 proteins studied. 
These  monoclonal  macroglobulins  are  often  associated  with  a  generalized 
lymphoproliferative disorder that  in some mice shows features  of malignancy. 
Materials and Methods 
Mice.--B/W mice were from our colony maintained at the Vivarium of the University of 
California at San Francisco. They were housed at the Veterans Administration Hospital and 
examined monthly under ether anesthesia for palpable tumors. Mice with palpable tumors were 
bled and serum proteins studied by agarose gel electrophoresis. Age- and sex-matched B/W 
mice without palpable tumors were also bled for serum protein studies. 
Serum Proteins.--Electrophoresis and  immunoelectrophoresis  were  performed  in  0.5% 
agarose buffered with 0.05 Veronal (pH 8.6). A constant current of 15 mA per 1 cm of agarose 
gel was maintained for 30 min. Immunoglobulins were precipitated with monospecific  goat 
antisera that were kindly furnished by Dr. Richard Asofsky.  The following anfisera were used: 
anti-IgM  (G135A),  anfi-IgA  (G134A),  antiIgG3'l  (G155),  anti-IgGT2  (G180),  and  anti-k 
(G135A2A). A rabbit anti-K antiserum was furnished by Dr. Rose Mage. Proteins and irnmuno- 
precipitin lines were stained with amido black 10B. Double diffusion  studies were also per- 
formed in 0.5% agarose buffered with 0.05 Veronal (pH 8.6). 
Isolation of IgM.--IgM  was isolated from B/W mouse serum by gel filtration on Sephadex 
G-200 columns. To eliminate a2-macroglobulin,  these filtrates were subjected to agarose or 
Pevikon preparative electrophoresis in 0.05 Veronal (pH 8.6). A constant current of 20 mA per 
1 cm was maintained for 6 h. The IgM was recovered by elution from Pevikon or by freeze- 
thawing from agarose. It was concentrated and studied for light chain type by double diffusion 
in agarose. 
Preparation of Anti-Idiotyplc Antisera.--The isolated IgM from two sera was emulsified in 
complete Freund's adjuvant and used to immunize rabbits.  Each rabbit received two 1 ml 
injections into multiple footpad, subcutaneous,  and intramuscular sites.  Rabbits were bled 2 
wk after the second injection. 1 ml of antiserum was absorbed with 0.4 ml of pooled electro- 
phoretically normal B/W mouse serum. 
Sucrose Gradient Ultracentrifugation.--Selected mouse sera were subjected to ultracentrifu- 
gation in a 10-35% sucrose  gradient (0.15 M NaCI, pH 8.0) using an SW 40 rotor (Beckman 
Instruments,  Inc., Spinco Div., Palo Alto, Calif.). The centrifugafion was at 39,000 rpm for 
20 h. The 13.5 ml gradient was collected dropwise into fractions and analyzed for antibodies to 
DNA and RNA using a cellulose ester filter radioimmunoassay, and for immunoglobulin con- 
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[3H]reovirus double-stranded RNA (33) and [14C]KB cell  DNA (34). The radioactive antigen- 
antibody complexes were collected on cellulose ester filters (Millipore Corp., Bedford, Mass.) 
and assayed for radioactivity in a liquid scintillation counter as previously described (33). 
Cytotoxicity Assay.--Cells from the  enlarged lymph  nodes were teased in RPMI  1640 
medium (Microbiological  Associates, Bethesda, Md.). Cells were washed three times in me- 
dium and adjusted to a concentration of l0  T cells/ml. Viability, determined by trypan blue 
dye exclusion, was 90% or greater. Surface antigens were studied in a cytotoxicity assay (14) 
using antimouse immunoglobulin sera and a heterologous antimouse T cell serum. The latter- 
was prepared by immunizing rabbits against mouse brain followed by absorption with mouse: 
liver cells. Its specificity for T cells was confirmed by reactivity with mouse thymocytes and 
lack of reactivity with bone marrow cells (35). 50 #1 of the cell suspension were mixed with 5@ 
#1 of appropriately diluted antisera and incubated with rocking for 45 rain at 37°C. The cells. 
were washed twice and 50 #1 of diluted rabbit complement (Hyland Div., Travenol Labora- 
tories, Costa Mesa, Calif.) was added. Mter incubation for 30 min at 37°C, trypan blue was 
added and cell viability determined. 
Tumor  Transplantation.--Enlarged  lymph nodes, spleen, and other organs were routinely 
examined by light microscopy. Certain specimens were fixed in glutaraldehyde and examined 
by electron microscopy. Many attempts were made to establish a transplanted tumor line by 
injecting 5 X  106 to 5 X  108 spleen or lymph node cells into syngeneic newborn or adult 
recipients. 
RESULTS 
Electrophoretically Restricted Proteins.--The  sera of B/W mice were studied 
by agarose gel electrophoresis for the presence of electrophoretically restricted 
proteins. In male mice 8-11 mo old, only 1 of  13 sera  (8%)  had  this finding 
(Table I). Between 11 and 17 mo of age, 37 of 117 mice (31.6%)showed such 
TABLE I 
Incidence of Electrophoretically Restricted Proteins and Palpable Tumors in B/W Mice 
Sex  Age  Electrophoretically  Palpable tumor 
restricted proteins 
mo 
Male  8-11  1/13  (8%)  13/136  (10%) 
Male  11-17  37/117  (31.6%)  117/362  (32.4%) 
Female  11-13  4/11  (36.4%)  11/47  (23.4%) 
Male  12-18  1/29  (3.4%)  0/29  (0%) 
proteins in the "y-region. The frequency in female mice 11-13 mo old was 4 out of 
11  (36.4 %).  The proteins varied in amount but many had the appearance of 
typical M-spikes (Fig. 1). 
Physical examination showed that these electrophoretic abnormalities were 
common in mice with palpable tumor masses.  For example, only 1 of 29 age- 
matched male mice without  tumors had  an M-spike  (Table I).  The  tumors 
were  generally subcutaneous nodules in the  cervical or  inguinal region  that 
histologically proved to be very enlarged and somewhat atypical lymph nodes? 
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Immunochemical  Characterization.--20  sera  containing  relatively  large 
amounts  of  these  electrophoretically  restricted  proteins  were  further  studied 
by  immunoelectrophoresis  with  specific  anti-immunoglobulin  antisera.  In 
every instance,  the protein  belonged  to the IgM immunoglobulin  class.  Many 
of these immunoglobulins  had typical features of monoclonal immunoglobulins 
(Fig.  2). 
The  macroglobulin  nature  of  these  IgM  proteins  was  confirmed  by  gel 
filtration on Sephadex G-200, by analytical ultracentrifugation,  and by sucrose 
gradient ultracentrifugation.  These indicated a high molecular weight immuno- 
globulin  with  an  approximate  s20 value  of  17. 
FIG. 1.  Agarose gel electrophoresis of normal B/W mouse serum and individual sera from 
older B/W mice showing electrophoretically  restricted proteins. 
FIo. 2.  Immunoelectrophoresis  of serum 99 developed with monospecific antisera to mouse 
immunoglobulins  indicating  that the restricted  protein is an IgM. Two other sera with re- 
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10 of these  IgM proteins  were isolated  by gel filtration  on  Sephadex  G-200 
and then studied by imlnunodiffusion with specific anti-kappa and anti-lambda 
antisera.  In every instance,  only a  single light  chain  type was found  (Fig.  3). 
Five of them were K-type and five were k-type (Table II). 
Idiotype Characteristics.--Two  of the  IgM proteins  (108,  141)  were isolated 
by gel filtration on Sephadex G-200 and further purified by Pevikon or agarose 
FIG. 3.  Double diffusion in agarose  of serum 100 and  108 with monospecific antisera to 
IgM (/z-chain), K- and X-chains. Serum 100 is an IgM K-type and serum 108 is an IgM X-type. 
The actual experiment is shown on the left and schematically  on the right. Reactions between 
antisera are due to materials added during absorption. 
TABLE  II 
Light Chain Type of Monoclonal IgM 
Number  Kappa  Lambda 
4  + 
28 
39  + 
72  + 
85 
99  + 









block electrophoresis.  They were then used to immunize rabbits for the prepa- 
ration  of  anti-idiotypic  antisera.  After  absorption  of  the  rabbit  antisera, 
typical  idiotypic  reactivity  was  observed  (Fig.  4).  The  absorbed  antisera  to 
108 reacted strongly with  the homologous IgM and with  one of 20 other IgM 
proteins  (164)  but no longer had the characteristics  of an anti-IgM serum. The 
significance of this limited cross-reaction is under study. This experiment indi- 
cates  that  the  IgM  proteins  contain  individually  specific  determinants  and 
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Antibodies to Nucleic Acids.--The  spontaneous appearance of antibodies  to 
double-stranded  RNA  and  DNA  are  hallmarks  of  the  autoimmune  disease 
that  develops in  B/W  mice  (27,  36).  DNA  immune complexes are  involved 
in  the  pathogenesis  of  nephritis  (27).  We  studied  whether  the  monoclonal 
IgM proteins in these mice were antibodies to nucleic acids. 
The incidence of antibodies  to DNA and RNA in older B/W mice without 
monoclonal IgM was 96.4 % and 67.8 %, respectively (Table III). The incidence 
in age- and sex-matched B/W mice with monoclonal IgM was 50% and 40%, 
respectively. Thus, the monoclonal IgM seems to be associated with a reduced 
incidence of antibodies to nucleic acids. 
This question was further studied by fractionating two sera containing anti- 
Fro. 4.  Double diffusion in agarose with antiserum prepared against the monoclonal IgM 
108. Before absorption (A) the antiserum reacted with all IgM proteins. After absorption (B) 
IgM's 108 and 164 were still positive but the other sera were  no longer reactive. 
TABLE  III 
Incidence of Antibodies to DNA and RNA in Old B/W FI Male Mice 
Monoclonal IgM  Antibody to DNA  Antibody to RIgA 
No  27/28  (96.4%)  19/28  (67.8%) 
Yes  10/20  (50%)  8/20  (40%) 
bodies to nucleic acids and monoclonal IgM by sucrose  gradient  ultracentrifu- 
gation. The results (illustrated for one serum in Fig. 5) show that the antibodies 
to DNA and RNA are predominantly in the  7S region of the gradient, clearly 
separated from the  heavier monoclonal IgM. Thus,  the monoclonal IgM  ap- 
pears not to be an antibody to DNA or RNA. Further search for other antibody 
activities is continuing. 
T  and  B  Cells in Enlarged Lymph Nodes.--Although  the  enlarged  cervical 
lymph nodes  presented  as  tumor  masses,  histologically many lacked  certain 
characteristics  of  malignant  neoplasms.  A  detailed  report  on  this  aspect  is 
beyond the scope of this communication and will  appear separately.  1 
We studied  whether there was an increased  number of B  cells with surface 
IgM in  these enlarged nodes,  such as one finds in  the  blood of patients with 
Waldenstr6m's macroglobulinemia (37). To do this we employed a cytotoxicity 
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FIG. 5.  Top: Sucrose gradient ultracentrifugation  of serum 72 performed as described in 
Materials and Methods. Each of 42 fractions was assayed for antibodies to DNA and RNA by 
radioimmunoassay (33). The peak of antibody activity was in the 7S region of the gradient, 
Fractions  14 and 26 were studied  by electrophoresis and immunoelectrophoresi~. Bottom: 
Fraction 14 (from the 19S region of the gradient) contained the monoclonal IgM (as well as 
a2-macroglobulin). Fraction 26 contained predominantly IgG and other serum proteins. 
Antiserum to  mouse IgM  killed about 30%  of  the  lymphocytes, and anti-T 
cell  serum was  cytotoxic for  approximately 40%  of  the  cells.  These  results 
indicate neither  an  abnormal distribution of  T  and  B  lymphocytes in  the 
enlarged lymph nodes nor any great increase in cells with surface IgM. 
Transplantable  Tumor  Producing  Monoclonal  IgM.--Many  attempts  to 
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geneic newborn or adult mice were unsuccessful although continued observa- 
tion of the recipients is in progress. However, one mouse (141) was producing a 
k-type monoclonal IgYl  and had  an  enlarged  spleen.  Cell  suspensions from 
the spleen were injected subcutaneously into newborn B/W mice and intra- 
peritoneally into adult B/W mice. Within  1 too,  the newborn recipients de- 
veloped subcutaneous lymphoid tumors and a  monoclonal IgM that reacted 
with the anti-idiotypic serum prepared  against 141  (Fig. 6).  The tumor cells 
had the characteristics of medium to large lymphocytes (Fig. 7) and could be 
further transplanted  to  second  and  third  generation newborn  and  adult  re- 
cipients as solid tumors. 
FIG. 6.  Agarose gel electrophoresis of 141 ascites fluid, newborn recipient serum and adult 
recipient serum, ascites, and pleural fluid showing eleetrophoretically restricted IgM proteins. 
Double diffusion  in agarose (below) shows reactivity with anti-idiotype serum (anti-141  abs.), 
whereas three other monoclonal IgM proteins fail to react. 
The adult recipients of the  141  splenic lymphocytes developed ascites and 
pleural  effusions within 3  wk of transplantation. The serum, peritoneal,  and 
plural fluids all contained a  prominent k-type IgM paraprotein  that reacted 
with the anti-141 idiotypic antiserum (Fig. 6). 
DISCUSSION 
This report establishes the presence of monoclonal macroglobulinemia in a 
large number of B/W mice over 11 mo of age. The monoclonal nature of the 
IgM is shown by restricted electrophoretic mobility, characteristic appearance 
on immunoelectrophoresis, restriction to a single light chain type, and ability 
to induce anti-idiotypic antisera. 
These  monoclonal  macroglobulins  often  appeared  in  mice  with  enlarged SUSUMU  SUGAI,  RAO  :PILLARISETTY~  AND  NORMAN TALAL  997 
FIO. 7.  Electron micrograph of lymphoid tumor transplanted into newborn B/W recipients 
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cervical or inguinal lymph nodes as part of their generalized lymphoprolifera- 
tion (1, 2). Initially, we suspected that the lymphoid masses were synthesizing 
the monoclonal IgM. However, some mice had neck tumors without M-spikes 
and others had faint M-spikes  with no apparent tumors. Moreover,  surgical 
excision of enlarged  cervical lymph nodes in three mice caused no change in 
the amount of monoclonal IgM. 
We also suspected  that the lymph node enlargement  was due to malignant 
lymphoma. However, as commented upon by East (3), it is almost impossible 
by morphologic criteria  alone to determine whether malignancy is present in 
such lymph nodes. Furthermore, cytotoxicity  testing for T and B cells indicated 
a mixed lymphoid population in proportions expected for ordinary lymph nodes. 
This mixed cell population was further confirmed by immunofluorescent studies 
employing antisera to T and B cells.  1 Finally, repeated attempts to establish a 
transplantable neoplasm  by injecting lymphocytes from the enlarged  nodes 
into syngeneic recipients  were negative. 
By contrast, a transplantable line producing  a monoclonal IgM was estab- 
lished by transfer of spleen cells into newborn and adult recipients. This result 
suggested that cells in the original donor spleen were producing the monoclonal 
IgM and, because  of their transplantability, had malignant  characteristics. 
This line,  now  in  its  third transplant generation,  seems analogous  to  IgM- 
producing  tumors  induced in  BALB/c mice  by  mineral  oil  injection  (38). 
It is noteworthy that NZB  mice share  with BALB/c the ability to develop 
plasmacytomas after mineral oil injection (39). 
Further  evidence  that  the  monoclonal  IgM  was  produced  in  the  spleen 
came from studies  of immunoglobulin  synthesis using another mouse with an 
enlarged cervical lymph node and a monoclonal IgM. Immunoautoradiographic 
analysis after culture of lymphoid organs  with radioactive amino  acids indi- 
cated that the IgM paraprotein was produced  in the spleen and not in the 
enlarged  cervical  lymph  node3  Further  experiments  with  additional  mice 
are underway. 
Although X-light chains  are  rare  in  BALB/c IgG  and  IgA myelomas,  5 
of 10 B/W monoclonal IgM proteins that we studied were X-type. The best 
known  IgM-producing  Balb/c  plasmacytoma  (104E)  is  also  X-type  (38). 
Statistically it  seems likely that normal B/W mouse IgM may not  show a 
marked predominance  of d-light chains. 
Experience  with  animals  immunized  to certain types of antigens suggests 
that the B/W monoclonal macroglobulins  may have antibody activity (38). 
For  example,  Braun  and  Krause found  that  homogeneous  antibodies  were 
produced  by  rabbits  immunized  with  streptococcol  antigens  (40). Genetic 
factors influenced  production of these proteins  that showed  idiotypic cross- 
reactivity (41). 
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About 5 %  of mouse myeloma proteins have antigen-binding activity (38). 
These  monoclonal immunoglobulins, generally of  the  IgA  class,  react  with 
specific  antigens such  as nitrophenyls, phosphorylcholine, and  specific  sugar 
linkages such as al ~  3 dextrans and/~l ~  6 galactose. For example, 11 IgA 
myeloma proteins precipitate with pneumococcus C polysaccharide because of 
their specificity for choline or phosphorylcholine (38). Several of these myeloma 
proteins also share a common idiotypic specificity. 
In humans, certain IgM proteins that are cold agglutinins have properties 
of monoclonal immunoglobulins and share  cross-specificity (42).  Recently, a 
similar cross-idiotypic specificity has been found for monoclonal IgM proteins 
that  are  anti-3,  globulins  (43).  Such  monoclonal  "rheumatoid  factors"  are 
frequently associated with  "mixed cryoglobulinemia" (44)  or  Sj6gren's  syn- 
drome (45). 
The possible antibody activity and the significance of idiotypic cross-reac- 
tivity seen with the B/W monoclonal IgM proteins are under study. The sucrose 
gradient fractionation experiments indicate  that  they are  not  antibodies  to 
DNA or to RNA. 
This  finding of  monoclonal macroglobulinemia is  particularly remarkable 
when one considers that New Zealand Black and hybrid mice are models for 
human  autoimmune  diseases  such  as  systemic  lupus  erythematosus  and 
Sj6gren's  syndrome.  An  association  between  autoimmunity  and  lymphoid 
neoplasia has been observed  (46,  47).  Monoclonal macroglobulinemia occurs 
particularly  in  SjiSgren's  syndrome  (48).  A  generalized  lymphoproliferative 
disorder  of variable  malignant potential is  sometimes seen in  such patients 
and  has  been  termed  pseudolymphoma (48).  The  New Zealand  mice  with 
salivary  gland  lymphoid  infiltrates,  generalized  lymphoproliferation,  auto- 
antibodies,  and  now  monoclonal  IgM  seem  remarkably  analogous  to  this 
human condition. 
A possible contributing pathogenetic factor is latent virus infection. Stimu- 
lation of lymphocytes by graft-vs.-host reaction  can  activate latent murine 
leukemia virus  (49).  Leukemia virus is very prominent in the New Zealand 
mice and is probably implicated in their development of lymphoma and re- 
ticulum cell sarcoma (3,  28).  The exact contribution of viral or immunologic 
factors to the various pathologic events in these animals may become clearer 
through further investigation. Recent attention has focused on a  possible de- 
ficiency of suppressor T  cells normally capable  of suppressing autoantibody- 
producing B cell clones. A lack of such suppressor function, it is argued, permits 
the emergence of autoimmunity. This concept can now be extended to explain 
the emergence of monoclonal macroglobulins as well as autoantibodies in New 
Zealand mice. By analogy, it may also explain the production of autoantibodies 
and monoclonal IgM in human diseases such as Waldenstr6m's macroglobuline- 
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SUMMARY 
Serum monoclonal macroglobulins were detected in over 30% of NZB/NZW 
F1 mice greater than 11 mo of age. The monoclonal nature of the IgM was shown 
by restricted  electrophoretic  mobility,  characteristic  appearance  on immuno- 
electrophoresis,  restriction  to  a  single  light  chain  type,  and  ability  to induce 
anti-idiotypic  antisera.  The  monoclonat  macroglobulins  were  separated  from 
antibodies  to DNA and  RNA that  migrated  in  the  7S  region of sucrose gra- 
dients.  Enlarged  lymph  nodes  were  often  present  in  mice  with  monoclonal 
IgM,  and  a  transplantable  IgM-producing  lymphoid  tumor  was  established 
from the spleen of one animal. 
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